Skip to main content
OpenTrials

Clinical trial condition

Slow Virus Diseases

Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.

2,616 public trials 184 recruiting studies
Refine in advanced search Browse all conditions

Slow Virus Diseases trial results

Active, Not Recruiting

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

NCT06134362

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Almagro, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Francistown, Botswana
  • GSK Investigational Site Porto Alegre, Brazil
View all 33 locations
View Trial Details
Active, Not Recruiting

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

NCT06182241

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cervical Cancer, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston University Boston, Massachusetts, United States
  • MatCH Research Unit (MRU), a Division of the Wits Health Consortium, University of Witwatersrand Durban, KwaZulu-Natal, South Africa
View Trial Details
Active, Not Recruiting

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

NCT05404750

Conditions
Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Allegheny Health Network Research Institute Pittsburgh, Pennsylvania, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

NCT06497504

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

NCT02951052

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 113 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

NCT07053384

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 41 locations
View Trial Details

Related conditions